David Bingaman, DVM, PhD, serves as the Chief Development Officer of Ora, where he oversees all clinical and non-clinical activities that directly impact customers around the world. With his background and leadership, Ora continues to elevate customer, patient and partner experiences while delivering outstanding development programmes. Before joining Ora, Dr Bingaman served in large public entities and small privately-held biotechnology companies. Prior employers include Alcon Laboratories, Alcon/Novartis, PanOptica and, most recently, Oculis, where he held the role of Vice-President and Head of Global Clinical Development. Dr Bingaman is a board-certified veterinary ophthalmologist with a PhD in Ocular Angiogenesis, patent holder, author and speaker.